D2M Biotherapeutics Announces First Patient Dosed in A Phase 1 Study Evaluating [Yahoo! Finance]
Laboratory Corporation of America Holdings (LH)
Last laboratory corporation of america holdings earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
April 18, 2024 /PRNewswire/ -- D2M Biotherapeutics, Inc. (D2M), a clinical stage biotech company focused on developing innovative therapies in treating Immunological-Inflammatory diseases and cancers, today announced that the first patient had been dosed in a phase 1, open-label, dose escalation and expansion study of DM919, a novel monoclonal antibody targeting MICA/B to restore and promote anti-tumor response by T and natural killer (NK) cells for the treatment of advanced solid tumors. This phase 1, first-in-human, multicenter, dose-escalation and expansion trial (NCT06328673) will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical activity of DM919 alone and in combination with anti-PD1 therapy in patients with advanced or metastatic solid tumors. "The initiation of this clinical study represents a major milestone for D2M," said Nan Bing , MD., Ph.D., co-founder and CEO of D2M. "The MICA/B targeted therapy is a novel modality in cancer treatment
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Laboratory Corporation of America Holdings news events
Weekly update
A roundup of the hottest topics
LH
News
- Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics, LabCorp climb following FDA testing oversight rule [Seeking Alpha]Seeking Alpha
- Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Labcorp's companion diagnostic approved for use with Pfizer's hemophilia B gene therapy [Seeking Alpha]Seeking Alpha
LH
Earnings
- 4/25/24 - Beat
LH
Sec Filings
- 5/1/24 - Form 4
- 4/30/24 - Form 144
- 4/30/24 - Form 10-Q
- LH's page on the SEC website